Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
American Stroke Association, Feb. 7-9
Feb 20, 2024
The conference featured presentations that emphasized basic, clinical and translational medicine and provided insight into the prevention, management and treatment of stroke.
Care management improves ROI for dementia-related care costs: study
By
Kathleen Steele Gaivin
May 28, 2024
Care management significantly improved healthcare costs, utilization and overall return on investment for Medicare managed-care people living with dementia who were enrolled in one dementia care management...
AI may help predict mortality in dementia patients
Mar 05, 2024
The prediction was feasible across time frames using certain clinical features.
The 5-Cog paradigm improves diagnosis, management of dementia
Jun 11, 2024
A threefold improvement was seen in dementia care actions with the 5-Cog paradigm, a culturally adept cognitive detection tool.
Caregivers, not just people with dementia, need screenings, interventions for loneliness, study shows
By
Kimberly Bonvissuto
Mar 20, 2024
Isolation and loneliness are a shared experience and a source of distress not only for people with dementia, but also their caregivers, according to new study findings.
More news for Friday, Nov. 3
By
Kimberly Bonvissuto
Nov 03, 2023
Neighoborhood environments can influence modifiable factors for Alzheimer’s, dementias … Former assisted living owner to undergo competency evaluation in exploitation case … Enhanced tai chi program...
Report: Most federally funded clinical trials for dementia have racially excluding criteria
By
Kristen Fischer
Jul 10, 2024
A team of investigators looked at possible dementia clinical trial requirements that could exclude people based on race and ethnicity. Overall, 82% of the trials they examined had criteria that weren’t...
4 percent of those aged 65+ have dementia diagnoses: report
By
Kimberly Bonvissuto
Jun 14, 2024
Four percent of US adults aged 65 or more years have a dementia diagnosis, with rates of dementia increasing with age, according to newly released data.
Menopausal hormone therapy use beyond 65 years beneficial
Apr 16, 2024
Use of menopausal hormone therapy beyond age 65 years is associated with risk reductions in mortality as well as specific cancers and cardiovascular diseases, according to a study published online April...